Sensyne’s gestational diabetes AI app launches on the NHS

Artificial intelligence company Sensyne Health has launched a new app that helps women manage gestational diabetes, and five NHS hospitals have already signed up. GDm-Health is a tool enabling remote management of gestational diabetes, reducing the need for expectant mothers to attend additional medical appointments and reducing pressure on midwives and NHS services.
The app, an approved device that complies with requirements in the European Medical Directive, allows patients to connect a blood glucose meter to their smartphone so they can monitor and securely submit real-time via an app.